Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationBone MarrowBone Marrow TransplantationTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningBone Marrow CellsStem CellsHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationGraft SurvivalTransplantation ChimeraTreatment OutcomeTissue DonorsHematopoiesisWhole-Body IrradiationCord Blood Stem Cell TransplantationHistocompatibility TestingBone and BonesBusulfanRetrospective StudiesAntigens, CD34HistocompatibilityHematopoietic Stem Cell MobilizationLeukemiaMyeloablative AgonistsCell DifferentiationLiver TransplantationRecurrenceChimerismGraft vs Leukemia EffectTime FactorsMice, Inbred C57BLImmunosuppressive AgentsMultiple MyelomaMesenchymal Stem Cell TransplantationHematologic DiseasesCombined Modality TherapyRemission InductionCell LineageLeukemia, Myeloid, AcuteFlow CytometryMyelodysplastic SyndromesColony-Forming Units AssayHepatic Veno-Occlusive DiseaseHLA AntigensSurvival RateCell TransplantationBone Marrow DiseasesStem Cell NicheKidney TransplantationSiblingsSurvival AnalysisVidarabineUnrelated DonorsTransplantation ImmunologyAnemia, AplasticDisease-Free SurvivalPostoperative ComplicationsGraft vs Tumor EffectCells, CulturedTransplantation, IsogeneicCyclophosphamideSevere Combined ImmunodeficiencyMelphalanEmbryonic Stem CellsAdult Stem CellsLymphocyte TransfusionGranulocyte Colony-Stimulating FactorFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaFetal BloodLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesCell SeparationAcute DiseaseCytomegalovirus InfectionsMesenchymal Stromal CellsSalvage TherapyBone Marrow ExaminationLymphocyte DepletionAntilymphocyte SerumAntineoplastic Combined Chemotherapy ProtocolsGraft RejectionImmunosuppressionCell ProliferationBone Marrow PurgingLymphoma, Non-HodgkinDonor SelectionStem Cell FactorAllograftsLeukemia, MyeloidBone RemodelingPrognosisMultipotent Stem CellsRisk FactorsOpportunistic Infections